Complete ATHA Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
ATHA Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 9 peer companies in Healthcare
P/E Ratio
$-38.77
-11636.6%
Peer Median: 19.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 2.6x
P/S Ratio
$0.00
-100.0%
Peer Median: 2.2x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for ATHA's business model and current situation.
Multiple Comparison
| Multiple | ATHA Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -0.2x | 19.0x | 22.3x | -100.9% | Undervalued |
| EV/EBITDA | -Infinityx | 2.6x | 12.5x | -Infinity% | Undervalued |
| P/S Ratio | Infinityx | 2.2x | 4.7x | Infinity% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.02B | 0.0x | 0.0x | 31.9x | |
| $0.02B | 0.8x | 2.6x | 2.2x | |
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 7.6x | 1.4x | 0.1x | |
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 1.5x | |
| $0.01B | 19.0x | 0.7x | 475.9x | |
| $722.17B | 61.8x | 45.1x | 14.7x |